HEALTHEQUITY, INC.

(HQY)
  Report
Real-time Estimate Cboe BZX  -  05/16 02:43:03 pm EDT
57.40 USD   -0.49%
05/02HEALTHEQUITY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/02HealthEquity Expands Board of Directors
AQ
05/02HealthEquity, Inc. Expands Board of Directors
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: January 2020 2021 2022 2023 2024 2025
Capitalization1 4 6826 4334 4684 866--
Enterprise Value (EV)1 5 7117 0905 1734 7604 8664 866
P/E ratio 114x696x-101x-91,3x-887x85,5x
Yield ------
Capitalization / Revenue 8,80x8,77x5,91x5,89x5,38x4,68x
EV / Revenue 10,7x9,67x6,84x5,76x5,38x4,68x
EV / EBITDA 29,1x29,4x21,9x18,9x16,3x12,5x
Price to Book 4,56x4,68x2,42x2,60x--
Nbr of stocks (in thousands) 70 87976 99183 60184 365--
Reference price (USD) 66,183,653,457,757,757,7
Announcement Date 03/16/202003/15/202103/22/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: January 2020 2021 2022 2023 2024 2025
Net sales1 5327347578269051 039
EBITDA1 196241236252298390
Operating profit (EBIT)1 77,035,7-24,2-27,935,1136
Operating Margin 14,5%4,87%-3,20%-3,37%3,88%13,1%
Pre-Tax Profit (EBT)1 43,24,14-66,7-71,6-8,9531,7
Net income1 39,78,83-44,3-53,7-7,4160,9
Net margin 7,46%1,20%-5,85%-6,50%-0,82%5,86%
EPS2 0,580,12-0,53-0,63-0,070,68
Dividend per Share2 ------
Announcement Date 03/16/202003/15/202103/22/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: January 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales1 189180203204205203
EBITDA1 65,561,150,455,365,767,3
Operating profit (EBIT)1 -0,88-0,37-27,3-13,8-3,63-2,44
Operating Margin -0,46%-0,20%-13,4%-6,77%-1,77%-1,20%
Pre-Tax Profit (EBT)1 -7,79-9,13-43,8-27,7-15,7-11,1
Net income1 -3,82-5,04-32,8-20,1-10,6-8,67
Net margin -2,02%-2,80%-16,1%-9,87%-5,15%-4,27%
EPS2 -0,05-0,06-0,39-0,25-0,12-0,10
Dividend per Share ------
Announcement Date 09/08/202112/06/202103/22/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: January 2020 2021 2022 2023 2024 2025
Net Debt1 1 029658705---
Net Cash position1 ---106--
Leverage (Debt / EBITDA) 5,24x2,73x2,99x-0,42x--
Free Cash Flow1 72,111713264,4205199
ROE (Net Profit / Equities) 15,3%10,5%6,81%5,42%--
Shareholders' equity1 26084,5-651-991--
ROA (Net Profit / Asset) 7,48%0,33%-1,52%-1,81%--
Assets1 5302 6772 9092 975--
Book Value Per Share2 14,517,922,122,2--
Cash Flow per Share2 1,532,401,702,021,94-
Capex1 32,913,18,9114,318,29,50
Capex / Sales 6,19%1,78%1,18%1,73%2,01%0,91%
Announcement Date 03/16/202003/15/202103/22/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 4 866 192 292
Net sales (USD) 756 556 000
Number of employees 3 702
Sales / Employee (USD) 204 364
Avg. Exchange 20 sessions (USD) 44 326 606
Average Daily Capital Traded 0,91%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA